Enanta Pharmaceuticals
ENTA
$12.13
Share price
-7.12%
Change (1 day)
-52.43%
Change (1 year)
Categories
Market capitalization of Enanta Pharmaceuticals (ENTA)
Market cap: $0.25 Billion
As of May 2024 Enanta Pharmaceuticals has a market cap of $0.25 Billion. This makes Enanta Pharmaceuticals the world's 6742th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Enanta Pharmaceuticals from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.25 B | 29.64% |
| 2023 | $0.19 B | -79.52% |
| 2022 | $0.96 B | -36.9% |
| 2021 | $1.53 B | 81.39% |
| 2020 | $0.84 B | -30.93% |
| 2019 | $1.22 B | -11.09% |
| 2018 | $1.37 B | 22.66% |
| 2017 | $1.12 B | 75.95% |
| 2016 | $0.63 B | 2.78% |
| 2015 | $0.62 B | -34.43% |
| 2014 | $0.94 B | 93.12% |
| 2013 | $0.49 B |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Enanta Pharmaceuticals was reported to be:
$0.25 Billion
$0.25 Billion
$0.25 Billion
$0.25 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $372.16 B | 144,765.76% | 🇺🇸 USA |
 Novartis NVS | $209.58 B | 81,478.93% | 🇨🇭 Switzerland |
 AbbVie ABBV | $293.87 B | 114,290.45% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $114.88 B | 44,619.75% | 🇺🇸 USA |
 Merck MRK | $332.27 B | 129,238.82% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $89.25 B | 34,641.56% | 🇺🇸 USA |